Pulmonary arterial hypertension (PAH) is a rare and severe disease characterized by an increase of pulmonary vascular resistance and right heart failure. Chronic hypoxia induces PAH, which is accompanied by functional (endothelial dysfunction, increased vasoconstriction) and structural (thickening of media) changes in pulmonary arteries. However, the mechanisms of these alterations remain unsolved. Among biological hallmark of this disease, level of circulating microparticles (MPs), small vesicles of plasma membrane released during cell activation and apoptosis, is increased in PAH patients. Although MPs can act as biological vectors of endothelial dysfunction, their role in PAH are not elucidated yet. We studied circulating MP effects on endothelial function during hypoxic PAH. Male Wistar rats were exposed or not to chronic hypoxia (3 weeks, 0.5 atmosphere) and normoxic or hypoxic MPs were isolated from peripheral blood and characterized by Á ow cytometry. Endothelial cells from rat normoxic aorta or pulmonary arteries were incubated for 24h with MPs. We studied also effects of in vivo treatment of MPs on vasomotricity, for this, normoxic or hypoxic MPs or vehicle were i.v. injected into rats, and 24h after, endothelial function were studied. Levels of circulating MPs from hypoxic rats was twice than MPs from normoxic rats (1568 Â± 174 vs 852 Â± 80 MPs/Âõl of plasma). In vitro treatment of endothelial cells with hypoxic MPs reduced NO production both in aortas and pulmonary arteries ; these effects were associated with enhanced phosphorylation of endothelial NO-synthase at their inhibitory site. By contrast, O2-production was increased only in endothelial cells from pulmonary arteries. In vivo injection of normoxic or hypoxic MPs into rats impaired to the same extent the endotheliumdependent relaxation induced by acetylcholine in aorta. Although pulmonary arteries from rat treated either with normoxic or hypoxic MPs displayed reduction of endothelium-dependent relaxation to carbachol compared to control, the deleterious effect of hypoxic MPs was greater than normoxic MPs. These data provide evidence that hypoxic circulating MPs induce in vitro and in vivo endothelial dysfunction by increasing oxydative stress and by decreasing NO production. Plasma levels of endothelial microparticles (EMPs) are markers of cardiovascular diseases and contribute to the pathogenesis of atherosclerosis. Laminar shear stress (SS) protects against plaque formation contrarily to oscillatory and low SS. We thus investigated whether different Á ow patterns (laminar, low or static) could affect EMP release.
Supported by ANR
HUVECs were subjected to high and low SS (15, 1.5 dynes / cm 2 ) or no SS (static) for 24 hours. EMPs were isolated from the culture medium and characterized by annexin V labeling using Á ow cytometry analysis. HUVECs exposed to high SS for 24 hours emitted 4 fold less AnnexinV+ EMPs compared to static (p<0.001) and 3 fold less compared to low SS (p<0.01) conditions. This Á owdependent EMP shedding was associated with the presence of 1.7 %±0.05, 3.75 %±0.1, 0.4 %±0.06 of TUNEL positive HUVECs in static, low and high conditions, respectively. Treatment of HUVECs with L-NAME (10-4M) signiÀ cantly increased EMPs in all conditions when compared to untreated cells. Similar EMPs increase was obtained when cells were treated with KT5720, a PKA inhibitor (10-6M) under low and high Á ow. We further characterized EMPs by determining their surface expression of ICAM-1. ICAM-1 expression on EMPs was signiÀ cantly increased in low SS and inhibited by high SS when compared to static conditions. Adhesion assays with EMPs-stimulated HUVECs (24hours) increased U937 cells capacity to attach in low SS-EMPs exposed to HUVECs compared to static and high SS EMPs stimulations. This effect was abolished with LFA-pretreated U937 before adhesion suggesting the pro-adhesive properties of low SS-EMPs bearing ICAM-1 at their surface.
Altogether, these À ndings indicate that high SS decreased the thrombotic and adhesive properties of EMPs, which might in part explain their anti-atherogenic effects, whereas low SS induced the shedding of prothrombotic, ICAM-1 positive EMPs, suggesting a novel way by which low SS might affect atherosclerosis. Background -La thrombose et l'inÁ ammation sont impliquées dans l'initiation et la progression de la lésion athéromateuse. Ainsi, de nombreuses cellules du compartiment vasculaire jouent un rôle clé dans la pathogenèse de la maladie coronarienne et ses complications. Déterminer précisément l'état d'activation de ces différents types cellulaires pourrait contribuer à identiÀ er les patients coronariens à haut risque d'événements récurrents.
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LES MICROPARTICULES POSITIVES POUR LE CD11B : UN MARQUEUR PREDICTIF DES EVENEMENTS RECURRENTS CHEZ LES PATIENTS CORONARIENS
Les microparticules (MP) sont des fragments de membrane désormais reconnus comme marqueurs À ables de l'activation et de l'apoptose cellulaires.
Objectif -Notre objectif a été de déterminer si les taux de MP issues de différents types cellulaires étaient associés à la sévérité des lésions athéromateuses et à la récurrence d'événements cardiovasculaires chez des patients coronariens.
Méthodes et Résultats -Les taux plasmatiques de MP ont été mesurés par cytométrie en Á ux chez 172 patients en attente de coronarographie à l'hôpital de la Timone. 77 patients (46 %) ont bénéÀ cié d'une pose de stent et ont été suivis durant 1 mois. 12 événements récurrents ont été rapportés pendant la période de suivi. Dans la cohorte totale, les taux de MP positives pour le marqueur d'activation leucocytaire CD11b (MPCD11b+) étaient signiÀ cativement plus élevés chez les patients traités par des statines (p = 0,001) et chez les patients ayant une fraction d'éjection préservée (p = 0,02). Les taux de MPCD11b+ étaient signiÀ cativement mais négativement associés à l'étendue des lésions athéromateuses coronaires évaluée par les données angiographiques et par le Syntax Score, ceci même après ajustement sur le traitement par les statines et sur la fraction d'éjection (p = 0,005). Au sein de la population stentée, les taux de MPCD11b+ étaient signiÀ cativement inférieurs chez les patients ayant présenté un événement récurrent (p = 0,0001). Cette différence restait signiÀ cative après ajustement sur le Syntax Score, sur la fraction d'éjection et sur le traitement par des statines (p = 0,03).
Conclusion -Les MPCD11b+ sont un marqueur biologique qui permet d'identiÀ er les patients coronariens à haut risque de récurrence indépendamment de la sévérité des lésions observées lors de la coronarographie. Recent studies have demonstrated that microparticles (MPs) generated from T lymphocytes undergoing both activation and apoptosis correct endothelial injury, and regulate angiogenesis. These effects are mediated by an increase of NO release and a decrease of reactive oxygen species (ROS) production. Apoptosis is an important mechanism that controls endothelial cell number and regeneration. We studied the effects of these MPs on human umbilical vein endothelial cell (HUVEC) apoptosis induced by actinomycin D (actD). Engineered MPs were obtained by activation of human lymphocyte CEM-T cell line with phytohemagglutinin and then, by stimulation with phorbol-12-myristate-13-acetate and actD. HUVECs were grown for 24h in absence or presence of the proapoptotic agent actD (1 õg/ml), and/or 10 õg protein/ml of MPs. In another set of experiments, endothelial cells were pre-incubated either with nonselective caspases inhibitor, z-vad.fmk (50 õm), PI3kinase inhibitor, LY294002 (10 õm), ERK inhibitor, U0126 (10 õm), NOS inhibitor, L-NA (100 õm), or the superoxide dismutase (SOD) mimetic, manganese(III)tetrakis-(1-methyl-4-pyridyl)-porphyrin pentachloride (MnTMPyP, 100 õm). The proportion of nuclei with hypodiploid DNA (sub-G1 peak) corresponding to apoptotic cells was determined by Á ow cytometry after staining with propidium iodide, and by microscopy using TUNEL labeling. Our results clearly indicate that activated/apoptotic T lymphocytes MP treatment signiÀ cantly reduces HUVEC apoptosis evoked by actD. Moreover, pancaspases inhibitor reduces the degree of cell death either in presence or in absence of MPs, indicating the implication of caspases in actD-induced apoptosis. Although, the PI3-kinase inhibitor induces apoptosis by itself, it does not blunt the capacity of MPs in reducing apoptosis induced by actD. In contrast, the inhibitory effect of MPs is prevented in the presence either of the ERK inhibitor or the NOS inhibitor. Interestingly, MnTMPyP reduces actD-evoked apoptosis and the protective effects of MPs. Thus, these MPs may act as an SOD mimetic under these experimental conditions. Altogether, T lymphocyte MPs evoked cell protection against apoptosis at the level of caspases inhibition, MAP kinases, NO and ROS formations. They underscore the potential therapeutic of such MPs against vascular pathologies in close association with apoptosis.
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MICROPARTICLES FROM T LYMPHOCYTES REDUCE ACTINOMYCIN-D INDUCED APOPTOSIS IN HUMAN ENDOTHELIAL CELLS
Supported by ANR-07-PHYSIO-010-01. Obstructive sleep apnea syndrome (OSAS) is a highly prevalent disease characterized by recurrent episodes of partial or complete obstruction of the upper airways during sleep, leading to oxygen desaturation, sleep fragmentation and clinical endothelial dysfunction. Microparticles (MPs) are membrane vesicles released during cell activation and apoptosis. Elevated levels of circulating MPs have been detected in pathologies associated with vascular alterations. We investigated the effects of MPs on endothelial function and vascular reactivity in OSAS. Blood samples were obtained either from 38 OSAS patients without any other cardiovascular comorbidities and 23 healthy subjects. A desaturation index above 10 per hour deÀ ned OSAS patients. MPs concentration and origin were assessed using Á ow cytometer. Male Swiss mice were injected i.v. with MPs from OSAS or healthy subjects, or with saline solution, and sacriÀ ed after 24 hours. Endothelial function and vascular reactivity were studied on aortic rings and small mesenteric resistance (SMA) arteries by myography and arteriography, respectively. Patients with OSAS did not display increased circulating levels of MPs compared to healthy subjects including those from pro-coagulant, platelet, endothelial, leukocyte and erythrocyte origins. Interestingly, MPs from granulocytes and activated leukocytes were signiÀ cantly enhanced in OSAS patients. Activated leukocyte MPs positively correlated with oxygen desaturation index. In aorta, MPs from OSAS patients but not those from healthy subjects signiÀ cantly reduced endothelium-dependent relaxation to acetylcholine. MPs from OSAS increased sensitivity of the aorta in response to serotonin that was greater compared to the effect of MPs from healthy subjects. In SMA, MPs from OSAS but not those from healthy subjects impaired Á ow-induced dilation without any effect on myogenic tone. Although SMA from mice
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INFLUENCE OF MICROPARTICLES HARVESTED FROM PATIENTS AFFECTED BY OBSTRUCTIVE SLEEP APNEA SYNDROME ON ENDOTHELIAL FUNCTION AND VASCULAR REACTIVITY
